DEA’s new effort to turn the tide on cannabis targets kids as public support for legalization and medical marijuana continues to rise nationwide.
In a case of a lesson in futility, the Drug Enforcement Administration (DEA) is launching another expensive effort against marijuana. The DEA’s new effort to turn the tide on cannabis is focused squarely on children and teens. The agency has unveiled a new youth-oriented education initiative designed to warn young people about the perceived risks of marijuana use, framing cannabis as a public health concern at a moment when national attitudes have never been more permissive.
RELATED: Why Anxiety Feels Worse Than Ever
According to the DEA, the program is meant to counter what it views as a normalization of cannabis driven by legalization, commercialization, and pop culture. Educational materials aimed at schools, parents, and community groups emphasize potential impacts on brain development, mental health, and academic performance. Officials argue today’s high-potency products present new risks young people may not fully understand, and they say prevention must start early.
The challenge for the agency is that it is swimming against a powerful cultural and political current. Cannabis is now legal for medical use in a majority of states and legal for adult recreational use in many of them. Polling consistently shows 88% of the public supports some form of legal marijuana, whether medical, recreational, or both. That support extends beyond voters to major medical organizations that acknowledge cannabis has therapeutic value when used appropriately and under medical supervision.
Medical marijuana is commonly prescribed for chronic pain, nausea associated with chemotherapy, multiple sclerosis symptoms, epilepsy, and PTSD. For many patients, cannabis is seen as a safer alternative to opioids or other pharmaceuticals with well-documented risks. Public health researchers also frequently point out that cannabis compares favorably to alcohol, which is legal nationwide despite its strong links to liver disease, addiction, impaired driving, and violence. While cannabis is not risk-free, its overall harm profile is widely viewed as lower than alcohol’s, particularly for adults.
Generational attitudes further complicate the DEA’s message. Support for legalization is overwhelming among Gen Z and millennials, who have grown up in an era of dispensaries, regulated products, and open discussion of medical use. More striking is the rapid shift among baby boomers, many of whom now support legalization after decades of opposition, often influenced by personal experience with medical cannabis for pain or age-related conditions.
RELATED: Is CBD Next On The Fed’s Hit List
Critics of the DEA’s new effort argue that education campaigns focused solely on abstinence and fear risk losing credibility with young people who see cannabis as socially accepted and medically legitimate. They say a more effective approach would emphasize honest, science-based information that distinguishes adult use from underage use, acknowledges medical benefits, and places cannabis in context alongside legal substances like alcohol.
As the national conversation continues to evolve, the DEA’s youth-focused campaign highlights a deeper tension in U.S. drug policy: how to protect children without ignoring the overwhelming public consensus that cannabis, in some form, is here to stay.
